Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Palantir Technologies Inc (PLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Palantir Technologies Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Palantir Technologies Inc trades at $198.47 (market cap $501.45B). The key difference: Palantir Technologies Inc is far larger — about 16.1× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Palantir Technologies Inc pays none. Which is the better fit depends on your goals.
| GEHC | PLTR | |
|---|---|---|
Market Cap | $31.07B | $501.45B |
Volume | 3,443,020 | 18,438,992 |
Sector | Health | Technology |
52-Week High | $88.16 | $209.05 |
52-Week Low | $59.48 | $107.27 |
Enterprise Value | $39.53B | $492.25B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 79 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Palantir (PLTR) trades at $200.97, down 3.84% on the day but maintains strong bullish technical momentum with consecutive earnings beats. The company demonstrates exceptional fundamental performance with 56.2% revenue growth in 2025, reaching $4.48 billion, and net income margin expanding to 36.3%. Recent partnership with Armada for sovereign AI infrastructure and consistent analyst optimism highlight the stock's growth trajectory despite premium valuation metrics.
Outlook remains positive with accelerating AI adoption driving growth, though elevated P/E of 178.35 presents valuation risk. Wall Street consensus targets $195.86 with 54% buy ratings, while technical indicators show potential resistance near $213-$219 levels. Key risks include growth normalization and competitive pressures in the expanding AI software market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Palantir Technologies Inc
Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →
